Loading clinical trials...
Loading clinical trials...
HF2 Therapy in the Treatment of Active Ulcerative Colitis:
Conditions
Interventions
HF2
Locations
2
Greece
Evaggelismos medical center
Athens, Greece
Sheba Medical Center
Ramat Gan, Israel
Start Date
May 29, 2019
Primary Completion Date
February 1, 2023
Completion Date
February 1, 2023
Last Updated
April 14, 2023
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Sheba Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions